![Richard Steinhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Steinhart
Finanzdirektor/CFO bei
BIOXCEL THERAPEUTICS, INC.
Vermögen: 83 510 $ am 31.05.2026
Profil
Richard I.
Steinhart currently serves as Independent Director at Atossa Therapeutics, Inc. since 2014, Independent Director at Actinium Pharmaceuticals, Inc. since 2013, and Senior VP, Chief Financial & Accounting Officer at BioXcel Therapeutics, Inc. since 2017.
Former positions include Independent Director at TG Therapeutics, Inc. from 2011 to 2012; Managing Director at Forest Street Capital, LLC from 1992 to 2006; Managing Director at SAE Ventures; Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992; CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2012 to 2013; Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992; Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017.
Education includes undergraduate and MBAistration degrees from Pace University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.05.2026 | 10’000 ( 0.12% ) | 52 300 $ | 31.05.2026 | |
| 15.06.2026 | 26’335 ( 0.18% ) | 30 812 $ | 31.05.2026 | |
| 15.10.2025 | 316 ( 0% ) | 398 $ | 31.05.2026 |
Aktive Positionen von Richard Steinhart
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.11.2013 |
| ATOSSA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.03.2014 |
| BIOXCEL THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.10.2017 |
Ehemalige bekannte Positionen von Richard Steinhart
| Unternehmen | Position | Ende |
|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Finanzdirektor/CFO | 01.04.2017 |
| STRATA SKIN SCIENCES, INC. | Finanzdirektor/CFO | 31.12.2013 |
| TG THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2012 |
Forest Street Capital, LLC | Corporate Officer/Principal | 24.04.2006 |
| EMISPHERE TECHNOLOGIES, INC. | Finanzdirektor/CFO | 01.05.1992 |
Ausbildung von Richard Steinhart
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
STRATA Skin Sciences, Inc.
 STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Forest Street Capital, LLC | |
SAE Ventures | |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
